Suvorexant Approval Status 
- FDA approved: No
- Generic name: suvorexant
- Company: Merck
- Treatment for: Insomnia
Suvorexant is an orexin receptor antagonist in development for use in patients with difficulty falling or staying asleep.
FDA Approval Status for suvorexant
| Date | Article |
|---|---|
| Nov 8, 2012 | Merck Announces FDA Acceptance of New Drug Application for Suvorexant, an Investigational Insomnia Medicine |
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
